45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,613
Insurances with rates
17
CPT / HCPCS codes
2,200
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9347 | IMJUDO 300MG/15ML | $261,261 | $156,757 | — | — | 20 |
| J0638 | CANAKINUMAB 150 mg Vial | $134,474 | $80,684 | — | — | 20 |
| J9309 | POLIVY 140 MG VIAL | $117,522 | $70,513 | — | — | 20 |
| J2507 | KRYSTEXXA 8MG/ML INJECTION | $113,483 | $68,090 | — | — | 20 |
| 33262 | RMV+REPL CVD GEN SINGLE | $100,164 | $60,098 | — | — | 20 |
| 33263 | RMV+REPL CVD GEN DUAL | $100,164 | $60,098 | — | — | 20 |
| 33264 | RMV+REPL CVD GEN MULTI | $100,164 | $60,098 | — | — | 20 |
| 33249 | INS/RPL DEFIB W/LEAD | $93,552 | $56,131 | — | — | 20 |
| J2350 | OCREVUS 300MG/10ML INJECTION | $90,295 | $54,177 | — | — | 20 |
| J9298 | OPDUALAG 240-80MG/20ML | $88,022 | $52,813 | — | — | 20 |
| C9399 | EDARAVONE ORAL KIT 50ML | $87,763 | $52,658 | — | — | 13 |
| J9316 | PHESGO 1200MG-600MG | $77,754 | $46,652 | — | — | 20 |
| J2329 | BRIUMVI 150 MG VIAL | $70,156 | $42,094 | — | — | 20 |
| C1882 | DEFIB MOMENTUM IS-1/DF-1/LV | $66,838 | $40,103 | — | — | 13 |
| J9272 | JEMPERLI 500MG/10ML VIAL | $66,651 | $39,991 | — | — | 20 |
| 33231 | INS DEFIB PULSE GEN W/M | $64,431 | $38,659 | — | — | 20 |
| J2267 | OMVOH 300 MG VIAL | $64,266 | $38,560 | — | — | 20 |
| J2327 | SKYRIZI 600MG/10ML | $61,647 | $36,988 | — | — | 20 |
| J9043 | JEVTANA 60MG/6ML INJECTION | $60,085 | $36,051 | — | — | 20 |
| C1721 | DEFIB LLLIVIA NEO DR-T DF1 | $58,097 | $34,858 | — | — | 13 |
| 33289 | TRANSCATH IMPLNT PAP SENSOR | $57,341 | $34,405 | — | — | 20 |
| J9119 | LIBTAYO 350MG/7ML VIAL | $53,074 | $31,844 | — | — | 20 |
| C1722 | DEFIBRILLATOR PERCIVA IS1/DF-4 | $52,091 | $31,255 | — | — | 13 |
| J9022 | ATEZOLIZUMAB 1200MG/20ML INJ | $49,346 | $29,608 | — | — | 20 |
| 93653 | EP ABLATE SUPRVNT ARRHY | $44,458 | $26,675 | — | — | 20 |
| 93654 | EP ABLATE VENT TACHY | $44,458 | $26,675 | — | — | 20 |
| 93656 | TX ATRL FIB PUL VEIN I | $44,458 | $26,675 | — | — | 20 |
| J9273 | TISOTUMAB 40 MG | $44,208 | $26,525 | — | — | 20 |
| J9144 | DARZALEX FASPRO | $44,174 | $26,504 | — | — | 20 |
| 33208 | INS/RPLC PCMKR ATRL&VNT | $41,257 | $24,754 | — | — | 20 |
| J1930 | SOMATULINE DEPOT 120MG/0.5ML S | $40,281 | $24,169 | — | — | 20 |
| J9228 | YERVOY 5MG/ML INJ 10ML | $39,863 | $23,918 | — | — | 20 |
| J9042 | ADCETRIS 50MG/10ML INJ 0.2ML | $39,442 | $23,665 | — | — | 20 |
| J9223 | ZEPZELCA 4 MG VIAL | $38,687 | $23,212 | — | — | 20 |
| J9332 | VYVGART 400MG/20ML | $38,245 | $22,947 | — | — | 20 |
| 0795T | TCAT INS 2CHMBR LDLS PM CMPL | $38,142 | $22,885 | — | — | 20 |
| 0796T | TCAT INS 2CHMBR LDLS PM RA | $38,142 | $22,885 | — | — | 20 |
| 0797T | TCAT INS 2CHMBR LDLS PM RV | $38,142 | $22,885 | — | — | 20 |
| 0801T | TCAT RMV&RPL 2CHMBR LDLS PM | $38,142 | $22,885 | — | — | 20 |
| 0802T | TCAT RMV&RPL2CHMB LDLS PM RA | $38,142 | $22,885 | — | — | 20 |
| 0803T | TCAT RMV&RPL2CHMB LDLS PM RV | $38,142 | $22,885 | — | — | 20 |
| J9329 | Tislelizumab 100 mg vial | $36,336 | $21,802 | — | — | 20 |
| J9301 | GAZYVA 1000MG/40ML VIAL | $35,864 | $21,518 | — | — | 20 |
| J3101 | TNKASE 50MG INJ | $35,210 | $21,126 | — | — | 20 |
| L8679 | NEUROSTIMULATOR F15 | $34,254 | $20,552 | — | — | 13 |
| 37242 | VASC OCCLUSION ARTERIAL | $34,237 | $20,542 | — | — | 20 |
| J3380 | VEDOLIZUMAB 300MG/5ML VIAL | $33,883 | $20,330 | — | — | 20 |
| J7169 | ANDEXXA 200MG VIAL | $33,655 | $20,193 | — | — | 20 |
| ALLOGRAFT GRAFIX XC 7.5X15 | ALLOGRAFT GRAFIX XC 7.5X15 | $33,516 | $20,110 | — | — | 13 |
| J2506 | NEULASTA 6MG 0.6ML INJECTION | $33,007 | $19,804 | — | — | 20 |
Showing top 50 of 4,613 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.